Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
The negative charges of dextran-sulfate (DS) used for low-density lipoprotein (LDL) apheresis activates the intrinsic coagulation pathway, in which plasma kallikrein acts on high-molecular-weight kininogen (HMWK) to produce large amounts of bradykinin. This study was undertaken to see whether bradykinin generated during DS LDL apheresis has some physiologic effects in vivo. The plasma levels of bradykinin and nitric oxide derivatives (NOx) were examined when either of 2 anticoagulants, heparin or nafamostat mesilate (NM), was used during DS LDL apheresis. Although anticoagulative action by NM depends on the inhibition of thrombin activity, this substance also inhibits the activity of plasma kallikrein. During apheresis using heparin, the marked increase in bradykinin levels (before apheresis, 18 +/- 3 (mean +/- SE, n = 5) pg/ml; after apheresis 470 +/- 140, p < 0.01) was associated with the increase in NOx (before apheresis 50 +/- 11 pg/ml; after apheresis 66 +/- 15). Interestingly, these changes in bradykinin and NOx levels were suppressed during apheresis using NM. The changes in plasma NOx levels were negatively correlated with those in blood pressures. These findings suggest that bradykinin generated during apheresis exerts some physiologic effects by means of activation of endothelium-derived relaxant factor (EDRF). Our results support the view that bradykinin produced during DS LDL apheresis has physiologic significance.
Kojima
S
S
Department of Clinical Research, Tohsei National Hospital, Shizuoka, Japan.
Ogi
M
M
Sugi
T
T
Matsumoto
Y
Y
Yoshitomi
Y
Y
Kuramochi
M
M
D000368:Aged; D001920:Bradykinin / Q000378:metabolism; D016264:Dextran Sulfate; D005260:Female; D006801:Humans; D007610:Kallikreins / Q000032:analysis; D008077:Lipoproteins, LDL / Q000302:isolation & purification*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000378:metabolism*; D010956:Plasmapheresis
D008077:Lipoproteins, LDL; D009569:Nitric Oxide; D016264:Dextran Sulfate; D007610:Kallikreins; D001920:Bradykinin